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Background: This study aims to evaluate the effectiveness of the photobiomodulation therapy (PBMT) in the treat-
ment of minor recurrent aphthous stomatitis (MiRAS) in children, in terms of pain relief, lesion size reduction and 
the parental satisfaction of the therapy.
Material and Methods: This randomized controlled study was carried out on 60 children with clinical diagnosis of 
MiRAS. Patients were randomized into two groups: group A receiving laser therapy and group B receiving sham 
therapy (placebo). Laser therapy (diode laser, λ: 645 nm) was administered on day 1 (T0) for three consecutive days. 
Patients were evaluated also on day 4 (T1), on day 7 (T2) and on day 10 (T3). Oral aphthous lesions size was assessed 
through a periodontal probe to measure the diameter length (mm); pain was evaluated through the Visual Analogue 
Scale (VAS); parental satisfaction was assessed through a questionnaire.
Results: The difference in the reduction of ulcers diameters between the two groups resulted statistically significant 
at T1 and at T2 (p<0.05). A statistically significant difference in pain reduction between two groups was found at T1 
(p<0.05). No statistically significant difference between the two groups of parents was found as concerns the parental 
acceptance of the procedure and the discomfort for the need of multiple appointments.
Conclusions: PBMT is to be considered effective in the treatment of MiRAS in children and well- accepted by the 
parents of the children themselves.
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Introduction
Recurrent aphthous stomatitis (RAS), with its frequen-
cy of 5-25%, is one of the most common oral muco-
sal disorders characterized by painful, recurrent single 
or multiple small oval or round ulcerations with well-
defined edges, having yellow or grey background with 
surrounding erythematous haloes (1). It can affect both 
adults and children (2).
Based on size, number and duration of the lesions, it can 
be classified into three types: minor (MiRAS), major 
(MjRAS), and herpetiformis ulcers (HUs) (3-4).
MiRAS, accounting for more than 80%–90% of RAS 
cases, typically shows lesions of less than 1 cm in diam-
eter and heals within 7–14 days without scar formation. 
MjRAS lesions exceed 1 cm in diameter and heal within 
20–30 days with scarring. HUs are characterized by 1–3 
mm, multiple and clustered lesions, which may coalesce 
into larger ulcers and take up to 15 days to heal (3-4).
RAS etiology is multifactorial, including immune 
system dysfunction, genetic factors, food allergens, 
nutrition deficiency, hormonal changes, local trauma, 
endocrine alterations, stress, chemical products and mi-
crobial agents (3-8).
A variety of treatments have been proposed over the last 
years, including topical anesthetics, analgesics, antisep-
tics, topical steroids, immunomodulating drugs, muco-
sal barrier gel, sucralfate and herbal remedies (7-13).
Although the ulcers are usually self-limiting, these le-
sions are particularly challenging in children as their 
debilitating nature may interfere with daily activities 
such as eating, swallowing and speaking (14). Children 
are also more prone to super-infections and hyper-sali-
vation and they may also suffer from lack of appetite, 
fatigue, difficulties in concentration and nervousness. 
In pediatric age it is therefore important to reduce 
symptoms and to accelerate the healing process.
The use of biostimulating lasers has recently proven 
useful in several medical fields for treating chronic and 
acute pain conditions thanks to its anti-inflammatory 
and analgesic effects. In fact, it promotes re-epithelial-
ization, fibroblasts proliferation, collagen synthesis, it 
increases vascularity and decreases the alterations in 
nerve impulse conduction (14).
In a recent study, Rocca et al. (15) analysed the effect of 
the laser treatment of aphthous lesions in adult patients 
with four devices available on the market, two with 
wavelength in the infra-red region (2940 nm 808 nm) 
and two with a wavelength in the visible region (450 nm 
and 645 nm). Diode lasers 808 nm and 450 nm showed 
similar results with an improvement starting already af-
ter the application and gradually improving until 7 days 
after treatment without any statistically significant dif-
ference between them. Diode 645 nm was the device 
gaining the earliest effect reducing the pain already 
during the treatment and maintaining it at low level im-
mediately after the laser application.
The aim of this study is to evaluate the efficacy of PBMT 
with a 645 nm diode laser in the treatment MiRAS in 
pediatric patients in terms of pain relief, lesions diam-
eters reduction and parental satisfaction of the therapy.
Material and Methods 
- Sample Selection
This randomized controlled study was carried out on a 
group of consecutive children (aged 5 to 12 years old) 
with clinical diagnosis of MiRAS ulcers referred to the 
Pediatric Dentistry Department of the Dental Clinic of 
Brescia (Italy). Enrollment criteria were clinical diag-
nosis of MiRAS according to the Stanley classification 
(ulcers less than 10 mm in size, sited on nonkeratinized 
mucosal surfaces, recurring at intervals of 1-4 months, 
healing in 7-10 days) (16). Exclusion criteria were 
chronic diseases (e.g. coeliac disease, IgA deficit, dia-
betes, etc.) and drug intake (e.g. antibiotics, antifungals, 
corticosteroids, hormone therapies, etc.).
Patients were randomized into two groups by a com-
puter code: group A which included patients receiving 
laser therapy and group B receiving sham therapy (pla-
cebo), i.e. the device was switched on but the hand piece 
did not work. Randomization was performed using an 
automatically generated list in a 1:1 block size for two 
patients. Patients included in the study were randomly 
assigned to one of the 2 groups. Operators who per-
formed the treatment were not blinded to the allocation 
group. The blindness of enrolled subjects was guaran-
teed by the sham treatment, which was indistinguish-
able from PBMT. Outcome evaluators were also blinded 
to the study group.
Dentist, patients and caregivers wore appropriate pro-
tective eyewear, following international safety proce-
dures. The patients and their caregivers were advised 
not to take any topical or systemic medications or prod-
ucts from day 0 to day 7.  Laser therapy was adminis-
tered on day 1 (T0) for three consecutive days. Pain and 
diameters of the lesions were assessed on day 1 (T0), on 
day 4 (T1), on day 7 (T2) and on day 10 (T3).
- Laser equipment
The laser device used for this trial was a diode laser 
(RAFFAELLO 980 BIO - Dental Medical Technologies 
– DMT S.r.l.). PBMT was administered by a trained 
dentist and irradiated in the sites of oral aphthous le-
sions with 645 nm wavelength, power 100 mW, spot size 
1 cm2, 30 s per cm2, energy density 10 J/cm2, continu-
ous mode. 
- Sham treatment 
Patients received the exact repetition of the treatment 
modality but without any laser emission: although 
switched off, the laser devices emitted the same sound 
and showed the same screen parameters when working 
in the effective PBMT modality.
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and data were analysed using Stata® software for Mac.
Estimating that there is a success percentage of 90 % 
on day 3 for the group treated through PBMT by laser 
and of 50 % for the control group, the minimum number 
of patients for the study, assuming alpha 0.05 and beta 
0.20 (study power = 80 %), was calculated to be 40 (at 
least 20 per group).
Results 
A total of 60 children (37 females and 23 males) with 
MiRAS were included in the study according to the en-
rollment criteria. Size of the lesions ranged from 5 mm 
to 8 mm. The involved oral sites were: upper and lower 
lip, buccal mucosa and soft palate.
Demographic and clinical features are summarized in 
Table 1. The number of lesions and the lesion diame-
ters before therapy were similar for the two treatment 
groups (p>0.05).
- Lesions diameters
At T0, the mean of lesion diameters was 6.82±1.52 mm 
for group A and 6.34±1.77 mm for group B. On the 
fourth day (T1), the mean decreased to 3.82±2.02mm 
for group A and 4.79± 1.60 mm for group B; after seven 
days (T2), the mean resulted 2.40±0.5 mm in group A 
and 3.20±0.5mm in group B. Both groups showed a pro-
gressive reduction in ulcer extension, with a complete 
healing on day 10. The difference in the reduction of 
ulcer diameters between the two groups resulted statis-
tically significant at T1 and at T2 (Table 2).  
- Pain evaluation
The medians of VAS at the three intervals and p-values 
are displayed in Table 2. A statistically significant dif-
ference in pain reduction between two groups resulted 
only at T1 (p<0.05). No pain was reported after 10 days 
from the beginning of the treatment.
- Parental acceptance of the procedure
No statistically significant difference between the two 
groups of parents was found concerning parental accep-
tance of the procedure and the discomfort for the need 
of multiple appointments (Table 3).
- Aphthous ulcerations diameters
Oral Aphthous lesions were measured through a peri-
odontal probe to score the diameter length (mm). The 
scoring was performed on day 1 (immediately before 
the beginning of treatment) (T0), on day 4 (T1), on day 7 
(T2) and on day 10 (T3) as follow-up by three calibrated 
clinicians. The clinicians who prescribed the therapy 
were not involved in lesion measurement.
- Pain Scoring
Pain was evaluated through the Visual Analogue Scale 
(VAS) at the same timing of lesion measurement. Ac-
cording to this system, 1 indicates no pain and 10 indi-
cates severe pain; patients were asked to select a num-
ber from 1 to 10 on a ruler with icons faces to express 
the intensity of their pain.
- Parental acceptance of the therapy
A questionnaire was handed out at T2 to evaluate the 
parental acceptance of the PBMT. The questionnaire 
used to examine the parental acceptance of PBMT was 
written in Italian language and consisted of questions 
divided into 2 parts. The first part of the survey includ-
ed demographic information of the parents while in the 
second part of the survey the parents were asked to rate 
their acceptance of the laser therapy and the discomfort 
for the need of multiple appointments. The rating was 
determined by a five-point scale ranging from 1 (unsat-
isfied) to 5 (very satisfied). The parents answered the 
survey in the waiting room and they were allowed suf-
ficient time to answer the questionnaire alone without 
any explanation of the examiner.
- Statistical Analysis
Statistical analysis was descriptive, including mean, 
standard deviation and percentiles for variables such as 
sex, age and localization. To compare the two groups, 
we analysed the data on gender, disease and parents ac-
ceptance as frequencies and percentages. Concordance 
or differences in the frequency distribution between the 
two groups were tested using the Exact Fisher’s test. 
Student t test was used to compare VAS and size be-
tween groups. A level of significance of 5 % was used 
 GROUP A (n=30) GROUP B (n=30) p-value
Male-Female 12:18 11:19 0.5 °
Age (years) 8.9±2.2 8.4±2.1 0.37^
N° aphthous ulcers (mean/patient) 2.4±0.9 (n=70) 2.5±1.2 (n=74) 0.57^
Site    
Upper Lip 10 14 0.5°
Lower Lip 23 20 0.5°
Buccal mucosa 28 33 0.5°
Soft Palate 9 7 0.5°
Significative value p<0.05; Mean±SD; Tests: °Exact Fisher’ test, ^T-Student test
Table 1: Demographic characteristics of the children.
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Discussion 
Minor RAS is a common painful inflammatory condi-
tion characterized by recurrent ulcers with surrounding 
inflammatory halos; the underlying etiology remains 
unclear and a standardized treatment is still not well 
defined (1). According to a recent review (17), the Au-
thors suggest identifying and managing the main pre-
disposing factors (such as vitamin deficiencies, coeliac 
disease, anemia) by a detailed clinical history and labo-
ratory test. Topical medications appear to be the first 
choice of treatment for MiiRAS. Such preparations do 
have limitations with respect to drug delivery, subse-
quent compliance and retention on the oral mucosa (18).
In the present study, the efficacy of the use of photobio-
modulation therapy (PBMT) in the treatment of MiRAS 
pediatric patients was evaluated, both in terms of pain 
relief and lesions size  reduction. From our results, the 
use of a diode laser with 645 nm wavelengths allowed a 
statistically significant reduction of the ulcers diameters 
at T1 and at T2. This finding is in agreement with a re-
cent randomized clinical trial in adults that reported a 
statistically significant reduction in lesion sizes at each 
follow-up time, especially on day 3 (19).
According to our results, PBMT determines a signifi-
cant pain reduction after three days of therapy (T1). This 
is in agreement with Aggarwal et al. (19), who reported 
a statistically significant reduction in pain by using a di-
ode laser (810nm) when compared to the sham therapy 
group. Lalabonova and Daskalov (20) also reported a 
statistically significant reduction in erythema dynamics 
and epithelisation time in the laser therapy group.
Even if the exact mechanisms through which the laser 
induces pain relief are still not clear, it has been demon-
strated that laser light has three main effects:  analge-
sia, anti-inflammation and promotion of wound healing. 
During its interactions with biological tissues, laser en-
ergy is converted into energy useful to cells; it induces 
an increase in ATP mitochondrial production, serotonin 
and endorphins release (21,22). Moreover, local blood 
circulation, cellular proliferation and protein synthesis 
are increased. It is known that anti-inflammation and 
analgesia are connected to both an increase of periph-
eral endogenous opioids and a decrease of pro-inflam-
matory cytokines and free oxygen radicals (21,22).
The parents of both patients in laser therapy as well as 
those in sham therapy well accepted the laser procedure 
and did not complain of any problems regarding the 
time spent for multiple appointments. This is probably 
due to the fact that the parents of children with canker 
sores consider these debilitating lesions deserving of 
any attempt to alleviate symptoms.
The encouraging results of our investigation support the 
choice of PBMT for treating MiRAS in children. Previ-
ous studies in adults have been conducted, investigating 
the influence of varying laser device parameters such 
as power, wavelengths and number of sessions, but in 
general PBMT resulted in a significant improvement 
of the disease. More RCTs studies are needed to define 
specific device parameters and protocols to be applied 
in the everyday clinical management of MiRAS in pae-
diatric patients.
References
1. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent 
Clin North Am. 2014;58:281-97.
2. Majorana A, Bardellini E, Flocchini P, Amadori F, Conti G, Cam-
pus G. Oral mucosal lesions in children from 0 to 12 years old: ten 
years’ experience. Oral Surg Oral Med Oral Pathol Oral Radiol En-
Lesion diameters
GROUP A GROUP B p-value
T0 6.82±1.52 6.34±1.77 0.31
T1 3.82±2.02 4.79± 1.60 0.0017*
T2 2.40±0.5 3.2±0.5 0.0001*
VAS medians
GROUP A GROUP B p-value
T0 4±1.9 4±2.07 1
T1 1±0.72 3±1.38 0.0001*
T2 1±0.12 1±0.92 1
p-value (T-student Test); *Significative value p<0.05
Table 2: Lesion diameters and VAS medians at T0, T1, T2.




- Mother 25 22 NS
- Father 5 8 NS
Parental educational level 
- Primary school 4 1
NS
- Middle school 6 11
- High school 20 12
- Graduation 10 6
Parental acceptance of the procedure
- Unsatisfied (1) 0 0
NS
- Low acceptance (2) 0 0
- Medium acceptance (3) 0 0
- Satisfied (4) 3 5
- Very satisfied (5) 27 25
Discomfort for the need of appointments 
- Unsatisfied (1) 0 0
NS
- Low acceptance (2) 0 0
- Medium acceptance (3) 0 0
- Acceptable (4) 10 12
- No problems (5) 20 18
Significative value p<0.05; NS= non significant values
Table 3: Demographic and educational characteristics of the 
parents, levels of acceptance of the procedure and discomfort 
for the needs of multiple appointments.
e553
Med Oral Patol Oral Cir Bucal. 2020 Jul 1;25 (4):e549-53. Laser therapy and canker sores in children
dod. 2010;110:e13-8.
3. Chavan M, Jain H, Diwan N, Khedkar S, Shete A, Durkar S. Recur-
rent aphthous stomatitis: a review. J Oral Pathol Med. 2012;41:577-83.
4. Scully C, Porter S. Oral mucosal disease: recurrent aphthous sto-
matitis. Brit J Oral Maxillofac Surg. 2008;46:198-206.
5. Cassi D, Magnifico M, Gandolfinini M, Kasa I, Mauro G, Di Bla-
sio A. Early Orthopaedic Treatment of Hemifacial Microsomia. Case 
Rep Dent. 2017;2017:7318715.
6. Cassi D, Di Blasio A, Gandolfinini M, Magnifico M, Pellegrino F, Pi-
ancino MG. Dentoalveolar Effects of Early Orthodontic Treatment in 
Patients With Cleft Lip and Palate. J Craniofac Surg. 2017;28:2021-26.
7. Brocklehurst P, Tickle M, Glenny AM, Lewis MA, Pemberton MN, 
Taylor J, et al. Systemic interventions for recurrent aphthous stomati-
tis (mouth ulcers). Cochrane Database Syst Rev. 2012;9:CD005411.
8. Mansour G, Ouda S, Shaker A, Abdallah HM. Clinical efficacy of 
new aloe-vera and myrrh-based oral mucoadhesive gels in the man-
agement of minor recurrent aphthous stomatitis: a randomized, dou-
ble-blind, vehicle-controlled study. J Oral Pathol Med. 2014;43:405-9.
9. Belenguer-Guallar I, Jimenez-Soriano Y, Claramunt-Lozano. A 
treatment of recurrent aphthous stomatitis. A literature review. J Clin 
Exp Dent. 2014;6:1168-74.
10. Deshmukh RA, Bagewadi A. Comparison of effectiveness of cur-
cumin with triamcinolone acetonide in the gel form in treatment of 
minor recurrent aphthous stomatitis: a randomized clinical trial. Int 
J Pharm Investig. 2014;4:138-41.
11. Montgomery-Cranny JA, Wallace A, Rogers HJ, Hughes SC, 
Hegarty AM, Zaitoun H. Management of recurrent aphthous atoma-
titis in children. Dent Update. 2015;42:564-6,569-72.
12. Sharda N, Shashikanth MC, Kant P, Jain M. Levamisole and low-
dose prednisolone in the treatment of recurrent aphthous stomatitis. 
J Oral Pathol Med. 2014;43:309-16.
13. Borha-Mojabi K, Mirmiran F, Nassiri-Asl M, Nazeman P, Jahani-
hashemi H. Therapeutic effects of “ibuprofen, diphenhydramine and 
aluminium MgS” on recurrent aphthous stomatitis: a randomized 
controlled trial. J Dent (Tehran). 2014;11:167-71.
14. Han M, Fang H, Li QL, Cao Y, Xia R, Zhang ZH. Effectiveness 
of laser therapy in the management of recurrent aphthous stomatitis: 
a systematic review. Scientifica (Cairo). 2016;2016:9062430.
15. Rocca JP, Zhao M, Fornaini C, Tan L, Zhao Z, Merigo E. Effect 
of laser irradiation on aphthae pain management: A four different 
wavelengths comparison. J Photochem Photobiol B. 2018;189:1-4.
16. Stanley HR. Aphthous lesions. Oral Surg Oral Med Oral Pathol. 
1972;33:407-16.
17. Belenguer-Guallar I, Jimenez-Soriano Y, Claramunt-Lozano. A 
treatment of recurrent aphthous stomatitis. A literature review. J Clin 
Exp Dent. 2014;6:1168-74.
18. Bardellini E, Amadori F, Conti G, Majorana A. Clinical efficacy 
of a solution composed by sodium bicarbonate and alginate, aloe 
vera, propoli, chamomile, calendula and honey, in the treatmet of 
minor recurrent aphthous stomatitis in children. Minerva Pediatr. 
2016;68:507-9.
19. Aggarwal H, Singh MP, Nahar P, Mathur H, Gv S. Efficacy of 
low-level laser therapy in treatment of recurrent aphthous ulcers—a 
sham controlled, split mouth follow up study. J Clinic Diagn Res. 
2014;8:218-21.
20. Lalabonova H, Daskalov H. Clinical assessment of the therapeu-
tic effect of low-level laser therapy on chronic recurrent aphthous 
stomatitis. Biotechnol Biotechnol Equip. 2014;28:929-33.
21. Hagiwara S, Iwasaka H, Okuda K, Noguchi T.  GaIAIs (830nm) 
low-level laser enhances peripheral endogenous opioid analgesia in 
rats. Lasers Surg Med. 2007;39:797-802.
22. Mizutani K, Musya Y, Wakae K, Kobayashi T, Tobe M, Taira K, 
et al. A clinical study on serum prostaglandin E2 with low-level laser 




The Authors disclose any financial and personal relationships with 
other people or organisations that could inappropriately influence 
their work.
Ethics
All patients’ parents or caregivers were informed about the research 
and signed an informed consent to take part.  The study protocol was 
approved by the local Ethics Committee (NP 3812-19) and performed 
according to the Declaration of Helsinki.
